Evidence map›Paper›PMID 38995832›Full record

ArticleJournal of medical microbiology2024

A high-throughput assay identifies molecules with antimicrobial activity against persister cells.

Maiken Engelbrecht Petersen, Liva Kjær Hansen, Alexander Alexandrovich Mitkin, Nicholas M Kelly, Thomas Keith Wood, Nis Pedersen Jørgensen, Lars Jørgen Østergaard, Rikke Louise Meyer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. OvercomingFrontiers in antibiotics · 2026
    Review
  4. Article
  5. Microbes Saving Lives and Reducing Suffering.Microbial biotechnology · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maiken Engelbrecht PetersenInterdisciplinary Nanoscience Centre (iNANO), Aarhus University, 8000 Aarhus C, Denmark.
Liva Kjær HansenInterdisciplinary Nanoscience Centre (iNANO), Aarhus University, 8000 Aarhus C, Denmark.
Alexander Alexandrovich MitkinInterdisciplinary Nanoscience Centre (iNANO), Aarhus University, 8000 Aarhus C, Denmark.
Nicholas M KellyPincer Biotech ApS, 8000 Aarhus C, Denmark.
Thomas Keith WoodDepartment of Chemical Engineering, Pennsylvania State University, University Park, USA.
Nis Pedersen JørgensenDepartment of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
Lars Jørgen ØstergaardDepartment of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
Rikke Louise MeyerInterdisciplinary Nanoscience Centre (iNANO), Aarhus University, 8000 Aarhus C, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCiprofloxacinHigh-Throughput Screening AssaysMicrobial Sensitivity TestsStaphylococcus aureusMicrobial ViabilityAnti-Bacterial AgentsCiprofloxacindrug developmentpersister cellsStaphylococcus aureus

Identifiers

PMID38995832
PMCPMC11316564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.